Freshly released! Check out our latest collaborative work between William Harvey Research Institute and #humanitasuniversity! Frontiers - Immunology #ptx3 Alessandra Nerviani @_Katriona Felice Rivellese @RMeS_UMR1229 frontiersin.org/articles/10.33…

Great opportunities to join our team at Experimental Medicine & Rheumatology!

Ultrasound assessment of hands and feet for synovitis at time of first clinical visit markedly reduces time to diagnosis in routine care. ☝️ This is why Rheumatologists must implement MSKUS more frequently in the office, when its use is justified. 👉

Thank you Expertscape: Your Source For Medical Experts for the acknowledgement! Experimental Medicine & Rheumatology @VersusArthritis

We are looking for an enthusiastic person who is looking to contribute to expanding our knowledge on resolution mechanisms to join our group. If this is you or you know someone who fits this description here is the application link...webapps2.is.qmul.ac.uk/jobs/job.actio…

FLAMIN-GO’s vision is to provide an organ-on-chip solution to open up a new avenue towards care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D-culturing and perfusion, of all the disease-relevant joint tissues.

EMR investigator contribute to exciting new research published in bioRxiv biorxiv.org/content/10.110… Reports use of single cell technologies to elucidate to an unprecedented level, the cellular diversity found in the disease tissue of patients with #Rheumatoid #arthritis

New research published in Nature Medicine shows that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid #arthritis (RA) patients. Experimental Medicine & Rheumatology qmul.ac.uk/media/news/202…

Analysis of the #R4RA trial identifies pretreatment synovial biopsy features associated with response to rituximab or tocilizumab, and leads to the development of models that might predict treatment benefit in patients with #rheumatoidarthritis nature.com/articles/s4159…

We have a fully funded #PhD project to develop a drug blocking ROR2 for disease modification in osteoarthritis, with a bioinformatics component. Join us in London! Apply by 20th July findaphd.com/phds/project/a… #osteoarthritis #cartilagebiology #bioinformatics Queen Mary University of London Versus Arthritis

What's hidden here? ▶️Invitation to an interesting event on Monday, June 13th fb.me/e/1OoB1oLAQ #RA #Rheumatoidarthrytis #diagnostics #cure

New approach to #rheumatoidarthritis and new hope for #RA patients. Thank you Alessandra Nerviani for very interesting talk! youtu.be/5hINWZjT9rI

#osteoporosis- The Silent Killer

Applications are invited for a #Bioinformatician role at the vibrant #EMR. This position would particularly suit an ambitious early career researcher: qmul.ac.uk/jobs/vacancies… #personalizemedicine #clinicaltrials

Great talk given yesterday by Dr Liliane Fossati-Jimack at the Nanostring European Summit in London. see the link 👉 nanostring.com/about-us/event……… One step closer to #precision medicine in #Rheumatoid Arthritis!!!

We are looking for a nurse to join our team! If joining a friendly team working to deliver personalised medicine to rheumatology patients sounds interesting to you, please feel free to get in touch.

We have a post-doc position available on neutrophil trafficking in ageing. Please get in touch if you love neutrophils, vascular biology, and cool imaging! Thanks for all the RTs too: nature.com/naturecareers/…

Are you a clinician interested in gaining experience in clinical trials & rheumatology? Here is an outstanding opportunity to work in one of the leading centres worldwide in biopsy-driven trials in RA!! click the link to apply 🧑‍🔬qmul.ac.uk/jobs/vacancies…

👇Check this out! A great opportunity to join our team!

NEW—Biopsy-driven trial in biologic-naive patients with #rheumatoidarthritis; stratification by synovial B cell status did not predict response to B cell depletion with rituximab compared with alternative treatment strategies (etanercept and tocilizumab) thelancet.com/journals/lanrh…